115 related articles for article (PubMed ID: 36216270)
41. An Update to the Malthus Model for Radiotherapy Utilisation in England.
Heritage S; Sundaram S; Kirkby NF; Kirkby KJ; Mee T; Jena R
Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e1-e9. PubMed ID: 35835634
[TBL] [Abstract][Full Text] [Related]
42. [Reference bases of radiotherapy under stereotaxic conditions for bronchopulmonary, hepatic, prostatic, upper aero-digestive, cerebral and bone tumors or metastases].
Barillot I; Antoni D; Bellec J; Biau J; Giraud P; Jenny C; Lacornerie T; Lisbona A; Marchesi V; Mornex F; Supiot S; Thureau S; Noel G
Cancer Radiother; 2018 Oct; 22(6-7):660-681. PubMed ID: 30195982
[TBL] [Abstract][Full Text] [Related]
43. A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT.
Zhang WY; Li HF; Su M; Lin RF; Chen XX; Zhang P; Zou CL
PLoS One; 2016; 11(7):e0159506. PubMed ID: 27438606
[TBL] [Abstract][Full Text] [Related]
44. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
45. Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials.
Tabrizi S; Trippa L; Cagney D; Aizer AA; Tanguturi S; Ventz S; Fell G; Bellon JR; Mamon H; Nguyen PL; D'Amico AV; Haas-Kogan D; Alexander BM; Rahman R
JAMA Netw Open; 2021 Mar; 4(3):e213304. PubMed ID: 33779742
[TBL] [Abstract][Full Text] [Related]
46. The impact of coronavirus outbreak on breastfeeding guidelines among Brazilian hospitals and maternity services: a cross-sectional study.
Gonçalves-Ferri WA; Pereira-Cellini FM; Coca K; Aragon DC; Nader P; Lyra JC; do Vale MS; Marba S; Araujo K; Dias LA; de Lima Mota Ferreira DM; Nieto G; Anchieta LM; de Cássia Silveira R; de Moura MDR; Tuma Calil VML; Moraes VCC; de Almeida JHCL; Magalhães M; Sonini TCB; Javorsky JB; Ribeiro ÉLA; Ferreira R; de Almeida LDC; Garbers R; da Silva Faria GM; Roosch A; de Mesquita ARA; de Oliveira Pinto RM;
Int Breastfeed J; 2021 Mar; 16(1):30. PubMed ID: 33789708
[TBL] [Abstract][Full Text] [Related]
47. Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada.
Ramanakumar AV; Annie B; Frederic L; Christine B; Cathy R; Jean L
Cancer Med; 2023 Mar; 12(5):6260-6269. PubMed ID: 36385491
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the palliative radiotherapy pathway in a single institute: Can an MR Linac improve efficiency?
Benson R; Clough A; Nelder C; Pitt E; Portner R; Vassiliou M; McDaid L; Choudhury A; Rembielak A; Eccles C
J Med Imaging Radiat Sci; 2022 Jun; 53(2 Suppl):S44-S50. PubMed ID: 34922879
[TBL] [Abstract][Full Text] [Related]
49. [Radiotherapy of bone metastases in France: A descriptive monocentric retrospective study].
Le Fèvre C; Antoni D; Thiéry A; Keller A; Truntzer P; Vigneron C; Clavier JB; Guihard S; Pop M; Schumacher C; Salze P; Noël G
Cancer Radiother; 2018 Apr; 22(2):148-162. PubMed ID: 29602695
[TBL] [Abstract][Full Text] [Related]
50. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
[TBL] [Abstract][Full Text] [Related]
51. Effect and Toxicity of Radiation Therapy in Selected Palliative Indications.
Pechačová Z; Zemanová M; Končeková J
Klin Onkol; 2018; 31(6):439-447. PubMed ID: 31035767
[TBL] [Abstract][Full Text] [Related]
52. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
53. THE IMPACT OF COVID-19 ON HEAD AND NECK CANCER TREATMENT DELAY.
Gršić K; Blivajs I; Pastorčić Grgić M; Prgomet D; Lukinović J; Vugrinec O; Matoc L; Miličić B; Leović D
Acta Clin Croat; 2022 Oct; 61(Suppl 4):19-25. PubMed ID: 37250665
[TBL] [Abstract][Full Text] [Related]
54. COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients.
Lee S; Heo J
Med Oncol; 2021 Nov; 39(1):5. PubMed ID: 34739633
[TBL] [Abstract][Full Text] [Related]
55. Treatment delay and treatment pattern modifications among epithelial ovarian cancer patients during the COVID-19 pandemic: A retrospective cohort study.
Moterani VC; Moterani NJW; Candido Dos Reis FJ
J Surg Oncol; 2022 Dec; 126(7):1155-1161. PubMed ID: 35929947
[TBL] [Abstract][Full Text] [Related]
56. Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model.
Cellini F; Di Franco R; Manfrida S; Borzillo V; Maranzano E; Pergolizzi S; Morganti AG; Fusco V; Deodato F; Santarelli M; Arcidiacono F; Rossi R; Reina S; Merlotti A; Jereczek-Fossa BA; Tozzi A; Siepe G; Cacciola A; Russi E; Gambacorta MA; Scorsetti M; Ricardi U; Corvò R; Donato V; Muto P; Valentini V
Radiol Med; 2021 Dec; 126(12):1619-1656. PubMed ID: 34570309
[TBL] [Abstract][Full Text] [Related]
57. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
58. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.
Seibold P; Webb A; Aguado-Barrera ME; Azria D; Bourgier C; Brengues M; Briers E; Bultijnck R; Calvo-Crespo P; Carballo A; Choudhury A; Cicchetti A; Claßen J; Delmastro E; Dunning AM; Elliott RM; Fachal L; Farcy-Jacquet MP; Gabriele P; Garibaldi E; Gómez-Caamaño A; Gutiérrez-Enríquez S; Higginson DS; Johnson K; Lobato-Busto R; Mollà M; Müller A; Payne D; Peleteiro P; Post G; Rancati T; Rattay T; Reyes V; Rosenstein BS; De Ruysscher D; De Santis MC; Schäfer J; Schnabel T; Sperk E; Symonds RP; Stobart H; Taboada-Valladares B; Talbot CJ; Valdagni R; Vega A; Veldeman L; Ward T; Weißenberger C; West CML; Chang-Claude J;
Radiother Oncol; 2019 Sep; 138():59-67. PubMed ID: 31146072
[TBL] [Abstract][Full Text] [Related]
59. The impact of the COVID-19 pandemic on radiotherapy in Japan: nationwide surveys from May 2020 through June 2021.
Tamari K; Nagata Y; Mizowaki T; Kodaira T; Onishi H; Ogawa K; Shioyama Y; Shigematsu N; Uno T
J Radiat Res; 2023 Jan; 64(1):126-132. PubMed ID: 36109327
[TBL] [Abstract][Full Text] [Related]
60. Impact of the COVID-19 pandemic on the breast cancer early diagnosis program in Brazil.
Antonini M; Pinheiro DJPDC; Matos ABTMB; Ferraro O; Mattar A; Okumura LM; Lopes RGC; Real JM
Prev Med Rep; 2023 Apr; 32():102157. PubMed ID: 36846466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
